TY - JOUR
T1 - Radiation-Induced Liver Disease and Modern Radiotherapy
AU - Koay, Eugene J.
AU - Owen, Dawn
AU - Das, Prajnan
N1 - Funding Information:
Acknowledgments: Supported by the NIH/NCI under award number P30 CA016672. Dr. Eugene Koay was also supported by NIH (U54CA210181-01, 1U01CA200468, and 1U01CA196403), the Pancreatic Cancer Action Network (14-20-25-KOAY, 16-65-SING), the Radiological Society of North America (RSD1429), Project Purple, the Andrew Sabin Family Fellowship, and the Sheikh Ahmed Center for Pancreatic Cancer Research.
Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/10
Y1 - 2018/10
N2 - Modern radiotherapy techniques have enabled high focal doses of radiation to be delivered to patients with primary and secondary malignancies of the liver. The current clinical practice of radiation oncology has benefitted from decades of research that have informed how to achieve excellent local control and survival outcomes with minimal toxicities. Still, one of the most devastating consequences of radiation to the liver remains a challenge: radiation-induced liver disease (RILD). Here, we will review the current understanding of classic and nonclassic RILD from a clinical perspective, the evaluation and management of patients who are at risk of developing RILD, methods to reduce the likelihood of RILD using modern radiation techniques, and the diagnosis and treatment of radiation-related liver toxicities.
AB - Modern radiotherapy techniques have enabled high focal doses of radiation to be delivered to patients with primary and secondary malignancies of the liver. The current clinical practice of radiation oncology has benefitted from decades of research that have informed how to achieve excellent local control and survival outcomes with minimal toxicities. Still, one of the most devastating consequences of radiation to the liver remains a challenge: radiation-induced liver disease (RILD). Here, we will review the current understanding of classic and nonclassic RILD from a clinical perspective, the evaluation and management of patients who are at risk of developing RILD, methods to reduce the likelihood of RILD using modern radiation techniques, and the diagnosis and treatment of radiation-related liver toxicities.
UR - http://www.scopus.com/inward/record.url?scp=85051114104&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85051114104&partnerID=8YFLogxK
U2 - 10.1016/j.semradonc.2018.06.007
DO - 10.1016/j.semradonc.2018.06.007
M3 - Review article
C2 - 30309642
AN - SCOPUS:85051114104
SN - 1053-4296
VL - 28
SP - 321
EP - 331
JO - Seminars in Radiation Oncology
JF - Seminars in Radiation Oncology
IS - 4
ER -